CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec
Go back to CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec| (NASDAQ: CGON) | Delayed: 79.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.01 | 52 Week High | $ | |||
| Open | $79.01 | 52 Week Low | $ | |||
| Day High | $79.01 | P/E | N/A | |||
| Day Low | $79.01 | EPS | $ | |||
| Volume | 1,042 | |||||
